Clinical Trials Logo

Clinical Trial Summary

The trial will be carried out in Peking University People's Hospital. The whole trial will last 3 years. Amputees from orthopedics and vascular surgery will be distributed into two groups randomly and receive different treatments including traditional resection and regenerative peripheral nerve interface(RPNI) surgery.The pain outcome,the impact of post-amputation pain on life and the utilization rate of prostheses will be collected to study the efficacy, safety and prognosis of preventive regenerative peripheral nerve interface reconstruction in amputees. Investigators believe that RPNI can effectively reduce the incidence of post-amputation pain, reduce the degree of pain, improve the wearing rate of prostheses, and help patients return to normal life.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05554900
Study type Interventional
Source Peking University People's Hospital
Contact Guangxue Li
Phone 13581763702
Email luckylgx1012@163.com
Status Recruiting
Phase N/A
Start date May 12, 2020
Completion date December 31, 2023

See also
  Status Clinical Trial Phase
Terminated NCT04378062 - Pain After Proximal Digital Amputation Prevention N/A
Recruiting NCT05009394 - Surgical Treatments for Postamputation Pain N/A
Recruiting NCT03260400 - Short-term Implanted Electrodes Following Regenerative Peripheral Nerve Surgery for Improving Prosthetic Limb Control Signals N/A
Withdrawn NCT03957226 - An Osseoanchored Percutaneous Prosthesis Study Evaluating Stable Neural Signal Transmission in Subjects With Transhumeral Amputations N/A
Enrolling by invitation NCT04204668 - Surgical Treatments for Neuroma Pain in Amputees N/A